Snail plays an oncogenic role in glioblastoma by promoting epithelial mesenchymal transition

Jae Kyung Myung1, Seung Ah Choi2, Seung-Ki Kim2

  • 1Department of Pathology, College of Medicine, Seoul National University Hospital Seoul, Korea.

Abstract

Insights

Inhibition of the Snail gene in glioblastoma cells suppressed proliferation, migration, and invasion. This suggests Snail is a potential therapeutic target for glioblastoma treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Glioblastoma presents poor patient outcomes, necessitating research into progression factors.
  • The Snail gene's role in glioblastoma progression is not fully understood, despite its known involvement in epithelial mesenchymal transition (EMT) in other cancers.

Purpose of the Study:

  • To investigate the role of the Snail gene in glioblastoma progression.
  • To determine if Snail influences glioblastoma cell proliferation, viability, migration, and invasion.

Main Methods:

  • Utilized small interfering RNA (siRNA) to reduce Snail gene expression in three glioblastoma cell lines (KNS42, U87, U373).
  • Assessed changes in E-cadherin and vimentin expression.
  • Evaluated effects on cell proliferation, viability, invasion, migration, and cell cycle phase distribution.

Main Results:

  • Snail gene knockdown led to increased E-cadherin and decreased vimentin expression across all tested cell lines.
  • Inhibition of Snail significantly reduced glioblastoma cell proliferation, viability, invasion, and migration.
  • Observed an increase in cells within the G1 phase of the cell cycle following Snail knockdown.

Conclusions:

  • Snail gene knockdown effectively suppresses glioblastoma cell proliferation, viability, migration, and invasion.
  • Inhibition of Snail promotes EMT induction and affects cell cycle progression.
  • The Snail gene facilitates glioblastoma progression, highlighting its potential as a therapeutic target.

Related Concept Videos

Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.4K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
3.7K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.3K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K